Therefore, our results suggest that E1B-55 kD-deleted adenovirus may have therapeutic potential, especially in combination with adenoviral vector expressing K1–5, for the treatment of patients with bladder cancer. The gene discussed is KRT1; the disease is urinary bladder cancer.